Evotec SE (EVO) Net Equity Issued and Repurchased (2010)

Evotec SE (EVO) posted Net Equity Issued and Repurchased of $15.23 for Q1 2010.

Evotec SE (EVO) Net Equity Issued and Repurchased (2010) Analysis & Trends

Evotec SE has reported Net Equity Issued and Repurchased for 1 years, with the latest figure at $15.23 in Q1 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	-
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	700,000.00
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	84.80 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	Evotec SE	687.23 Mn	686.75 Mn	-	-

Download Data

Date	Value
Mar 31, 2010	15.23
Mar 31, 2010	15.23